Cantor Fitzgerald reiterated their hold rating on shares of National Health Investors (NYSE:NHI) in a report published on Wednesday morning. They currently have a $85.00 price objective on the real estate investment trust’s stock. Cantor Fitzgerald also issued estimates for National Health Investors’ FY2017 earnings at $5.27 EPS and FY2018 earnings at $5.60 EPS.
A number of other equities research analysts also recently issued reports on the stock. Zacks Investment Research downgraded shares of National Health Investors from a buy rating to a hold rating in a research note on Friday, November 17th. Capital One Financial began coverage on shares of National Health Investors in a research note on Monday, October 23rd. They issued an equal weight rating on the stock. KeyCorp reaffirmed an underweight rating on shares of National Health Investors in a research note on Tuesday, December 19th. ValuEngine raised shares of National Health Investors from a hold rating to a buy rating in a research note on Friday, November 10th. Finally, Stifel Nicolaus reaffirmed a buy rating and set a $82.00 target price on shares of National Health Investors in a research note on Wednesday, October 4th. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the stock. The stock presently has a consensus rating of Hold and an average price target of $81.25.
Shares of National Health Investors (NHI) opened at $69.80 on Wednesday. The stock has a market cap of $2,904.76, a P/E ratio of 13.42, a PEG ratio of 3.29 and a beta of 0.59. National Health Investors has a 52 week low of $68.96 and a 52 week high of $81.60. The company has a quick ratio of 12.72, a current ratio of 12.72 and a debt-to-equity ratio of 0.84.
National Health Investors (NYSE:NHI) last released its quarterly earnings results on Wednesday, November 8th. The real estate investment trust reported $0.94 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.34 by ($0.40). National Health Investors had a net margin of 59.70% and a return on equity of 12.74%. sell-side analysts anticipate that National Health Investors will post 5.26 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 31st. Investors of record on Friday, December 29th will be paid a dividend of $0.95 per share. This represents a $3.80 annualized dividend and a yield of 5.44%. The ex-dividend date of this dividend is Thursday, December 28th. National Health Investors’s payout ratio is currently 95.00%.
Institutional investors and hedge funds have recently made changes to their positions in the stock. Jacobi Capital Management LLC increased its stake in National Health Investors by 187.7% during the 3rd quarter. Jacobi Capital Management LLC now owns 1,827 shares of the real estate investment trust’s stock worth $142,000 after buying an additional 1,192 shares during the period. Fortaleza Asset Management Inc. increased its stake in National Health Investors by 123.7% during the 3rd quarter. Fortaleza Asset Management Inc. now owns 2,740 shares of the real estate investment trust’s stock worth $212,000 after buying an additional 1,515 shares during the period. Cubist Systematic Strategies LLC purchased a new stake in National Health Investors during the 3rd quarter worth approximately $237,000. Profund Advisors LLC increased its position in shares of National Health Investors by 4.3% in the 2nd quarter. Profund Advisors LLC now owns 3,126 shares of the real estate investment trust’s stock valued at $248,000 after purchasing an additional 130 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd purchased a new stake in shares of National Health Investors in the 3rd quarter valued at approximately $249,000. 70.52% of the stock is currently owned by hedge funds and other institutional investors.
About National Health Investors
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.